Ovaleap European Union - English - EMA (European Medicines Agency)

ovaleap

theramex ireland limited - follitropin alfa - anovulation - sex hormones and modulators of the genital system, - in adult womenanovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomifene citrate;stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer and zygote intra-fallopian transfer;ovaleap in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult menovaleap is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotropic hypogonadism with concomitant human chorionic gonadotropin (hcg) therapy.

Pergoveris European Union - English - EMA (European Medicines Agency)

pergoveris

merck europe b.v.  - follitropin alfa, lutropin alfa - infertility, female - sex hormones and modulators of the genital system, - pergoveris is indicated for the stimulation of follicular development in women with severe luteinising-hormone (lh) and follicle-stimulating-hormone deficiency.in clinical trials, these patients were defined by an endogenous serum lh level < 1.2 iu/l.

Bemfola New Zealand - English - Medsafe (Medicines Safety Authority)

bemfola

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 150 [iu] (11 mcg) - solution for injection - 600 iu/ml - active: follitropin alfa 150 [iu] (11 mcg) excipient: dibasic sodium phosphate dihydrate methionine monobasic sodium phosphate dihydrate phosphoric acid poloxamer sucrose water for injection - in adult men: bemfola is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Bemfola New Zealand - English - Medsafe (Medicines Safety Authority)

bemfola

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 225 [iu] (16.5 mcg) - solution for injection - 600 iu/ml - active: follitropin alfa 225 [iu] (16.5 mcg) excipient: dibasic sodium phosphate dihydrate methionine monobasic sodium phosphate dihydrate phosphoric acid poloxamer sucrose water for injection - in adult men: bemfola is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Bemfola New Zealand - English - Medsafe (Medicines Safety Authority)

bemfola

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 300 [iu] (22 mcg) - solution for injection - 600 iu/ml - active: follitropin alfa 300 [iu] (22 mcg) excipient: dibasic sodium phosphate dihydrate methionine monobasic sodium phosphate dihydrate phosphoric acid poloxamer sucrose water for injection - in adult men: bemfola is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Bemfola New Zealand - English - Medsafe (Medicines Safety Authority)

bemfola

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 450 [iu] (33 mcg) - solution for injection - 600 iu/ml - active: follitropin alfa 450 [iu] (33 mcg) excipient: dibasic sodium phosphate dihydrate methionine monobasic sodium phosphate dihydrate phosphoric acid poloxamer sucrose water for injection - in adult men: bemfola is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Bemfola New Zealand - English - Medsafe (Medicines Safety Authority)

bemfola

pharmacy retailing (nz) ltd t/a healthcare logistics - follitropin alfa 75 [iu] (5.5 mcg) - solution for injection - 600 iu/ml - active: follitropin alfa 75 [iu] (5.5 mcg) excipient: dibasic sodium phosphate dihydrate methionine monobasic sodium phosphate dihydrate phosphoric acid poloxamer sucrose water for injection - in adult men: bemfola is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.

Fostimon 75 IU inj. sol. (pwdr. + solv.) s.c./i.m. amp. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fostimon 75 iu inj. sol. (pwdr. + solv.) s.c./i.m. amp. vial

ibsa farmaceutici italia s.r.l. - urofollitropin 75 iu - powder and solvent for solution for injection - 75 iu - urofollitropin 75 iu/ml - urofollitropin

Fostimon 150 IU inj. sol. (pwdr. + solv.) s.c./i.m. amp. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fostimon 150 iu inj. sol. (pwdr. + solv.) s.c./i.m. amp. vial

ibsa farmaceutici italia s.r.l. - urofollitropin 150 iu - powder and solvent for solution for injection - 150 iu - urofollitropin 150 iu/ml - urofollitropin

Fostimon Kit 75 IU inj. sol. (pwdr. + solv.) s.c. pre-filled syr. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fostimon kit 75 iu inj. sol. (pwdr. + solv.) s.c. pre-filled syr. vial

ibsa farmaceutici italia s.r.l. - urofollitropin 75 iu/ml - powder and solvent for solution for injection - 75 iu - urofollitropin 75 iu/ml - urofollitropin